Publication:
Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice

dc.contributor.authorTripanichkul W.
dc.contributor.authorJaroensuppaperch E.-O.
dc.date.accessioned2021-04-05T03:32:59Z
dc.date.available2021-04-05T03:32:59Z
dc.date.issued2013
dc.date.issuedBE2556
dc.description.abstractBACKGROUND: Inflammation and oxidative stress are believed to contribute to neuronal degeneration of the nigrostriatal dopaminergic (DA) pathway in Parkinson's disease. Curcumin, a component of the yellow curry spice, has been reported possessing anti-inflammatory and anti-oxidative effects. AIM: The present study investigated the effects of curcumin on the extent of DA innervation, glial response, and Cu/Zn superoxide dismutase (SOD1) expression in the striatum of 6-hydroxydopamine (6-OHDA)-lesioned mice. MATERIALS AND METHODS: 6-OHDA was unilaterally injected into the right striatum of ICR male mice. Curcumin (200 mg/kg) was administered daily for 7 days starting instantaneously after 6-OHDA injection. Seven days after 6-OHDA insult, mice were euthanized and striatal sections were collected, immunohistochemically stained, and quantitated for tyrosine hydroxylase (TH), glial fibrillary acidic protein (GFAP), ionized calcium binding adapter molecule 1 (Iba1), and SOD1 immunoreactivity. RESULTS: 6-OHDA injection triggered a significant loss of TH-immunoreactive (-IR) axons, induced reaction of GFAP-IR astrocytes and Iba1-IR microglia, and decreased SOD1 expression in the 6-OHDA-lesioned striatum. Curcumin attenuated loss of TH-IR fibers, diminished activation of astrocytes and microglia, and sustained SOD1 level in the lesioned striatum. CONCLUSIONS: These results suggest that curcumin counteracts the neurotoxicity of 6-OHDA through its anti-inflammatory properties (inhibition of glial response) and preservation of SOD1 expression.
dc.format.mimetypeapplication/pdf
dc.identifier.citationEuropean Review for Medical and Pharmacological Sciences. Vol 17, No.10 (2013), p.1360-1368
dc.identifier.issn11283602
dc.identifier.other2-s2.0-84878621998
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6642
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.otherCalcium binding protein
dc.subject.otherCalcium binding protein iba1
dc.subject.otherCopper zinc superoxide dismutase
dc.subject.otherCurcumin
dc.subject.otherGlial fibrillary acidic protein
dc.subject.otherOxidopamine
dc.subject.otherTyrosine 3 monooxygenase
dc.subject.otherUnclassified drug
dc.subject.otherAnimal cell
dc.subject.otherAnimal experiment
dc.subject.otherAnimal model
dc.subject.otherAnimal tissue
dc.subject.otherArticle
dc.subject.otherAstrocyte
dc.subject.otherControlled study
dc.subject.otherCorpus striatum
dc.subject.otherDenervation
dc.subject.otherDopaminergic activity
dc.subject.otherGlia
dc.subject.otherImmunohistochemistry
dc.subject.otherImmunoreactivity
dc.subject.otherMale
dc.subject.otherMicroglia
dc.subject.otherMouse
dc.subject.otherNonhuman
dc.subject.otherParkinsonism
dc.subject.otherProtein expression
dc.subject.otherAnimals
dc.subject.otherAnti-Inflammatory Agents
dc.subject.otherCorpus Striatum
dc.subject.otherCurcumin
dc.subject.otherMale
dc.subject.otherMice
dc.subject.otherMice, Inbred ICR
dc.subject.otherNeuroglia
dc.subject.otherNeuroprotective Agents
dc.subject.otherOxidopamine
dc.subject.otherParkinson Disease
dc.subject.otherSuperoxide Dismutase
dc.subject.otherTyrosine 3-Monooxygenase
dc.titleAmeliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84878621998&partnerID=40&md5=1bada10e62ad317e984be7ba49cd4a40

Files